NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)

Agency: National Institutes of Health

93.279 -- Drug Use and Addiction Research Programs
93.242 -- Mental Health Research Grants
93.399 -- Cancer Control
93.121 -- Oral Diseases and Disorders Research
93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
93.273 -- Alcohol Research Programs

Open opportunityLast Updated: Oct 13, 2026

Description

The National Institutes of Health seek to advance their mission by providing the scientific community with the opportunity to request access to biospecimens from the Adolescent Brain Cognitive Development^SM (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population Assessment of Tobacco and Health (PATH) Study to conduct research consistent with the respective study objectives that will maximize the scientific utility of these limited samples. Applications should expand the knowledge gained from these studies and advance our understanding of the multiple genetic and environmental factors, such as exposure to substances, that affect health and disease over the course of a lifetime.

Eligibility

Eligible applicants

Business

Small businesses
For-profit organizations other than small businesses

Government

State governments
City or township governments
Public and Indian housing authorities
Special district governments
County governments

Education

Public and state institutions of higher education
Independent school districts
Private institutions of higher education

Nonprofit

Other Native American tribal organizations
Nonprofits non-higher education with 501(c)(3)
Nonprofits non-higher education without 501(c)(3)

Miscellaneous

Other

Additional information

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Grantor contact information

Description

National Institute of Drug Abuse (NIDA) nbdc_biobank@mail.nih.gov

Email

nbdc_biobank@mail.nih.gov

Documents

File name	Description	Last updated
PAR-27-051-Revised-Full-Announcement.html	PAR-27-051-Revised-Full-Announcement.html	Oct 13, 2026 02:41 PM UTC

Link to additional information

Closing: April 17, 2029

Application process

This site is a work in progress. Go to www.grants.gov to apply, track application status, and subscribe to updates.

Award

$--

Program Funding

Expected awards

$--

Award Minimum

$--

Award Maximum

Funding opportunity number:

PAR-27-051

Cost sharing or matching requirement:

Funding instrument type:

Grant

Opportunity Category:

Discretionary

Opportunity Category Explanation:

Category of Funding Activity:

Health

Category Explanation:

History

Version:

Posted date:

September 1, 2026

Archive date:

June 16, 2029